Related Experiment Videos
Circadian variations in cardiovascular disease
Insights
Circadian rhythms significantly impact cardiovascular events and thrombotic tendency. Understanding these daily variations is crucial for optimizing treatments like anticoagulants and thrombolytics.
Area of Science:
- Cardiovascular Physiology
- Chronobiology
- Hemodynamics
Background:
- Circadian variations affect numerous cardiovascular events, including heart rate, blood pressure, and cardiac events like myocardial infarction.
- Daily fluctuations are also noted in hemostasis, including platelet aggregation, fibrinogen levels, and fibrinolytic activity.
Purpose of the Study:
- To investigate the correlation between circadian variations in thrombotic tendency and cardiovascular events.
- To explore the clinical implications of these circadian variations on therapeutic responses.
Main Methods:
- Observational analysis of documented circadian variations in hemodynamic and cardiovascular parameters.
- Review of studies on thrombotic factors, including platelet response and coagulation/fibrinolysis.
- Correlation analysis between periodicities in thrombogenic capacity and cardiovascular events.
Main Results:
- Circadian variations are evident in heart rate, blood pressure, coronary blood flow, and major cardiovascular events.
- Significant daily variations exist in platelet aggregation, plasma fibrinogen, coagulation factors, and fibrinolysis.
- A direct correlation appears to exist between circadian periodicities in thrombogenic capacity and cardiovascular events.
Conclusions:
- Observed correlations suggest a cause-effect relationship between circadian thrombotic tendency and cardiovascular events.
- Circadian variations in thrombotic tendency may influence patient response to anticoagulants and thrombolytic therapies, such as rt-PA.
- Further research is warranted to fully elucidate the clinical significance of these circadian rhythms in cardiovascular disease management.
Abstract:
Circadian variations have been observed for a number of hemodynamic and cardiovascular events including heart rate, systemic blood pressure, coronary artery blood flow, ischemic cerebrovascular accidents, myocardial ischemia, myocardial infarction, and sudden cardiac death. In addition, circadian variations in platelet response to aggregating stimuli, plasma fibrinogen, coagulation factor concentration, and intrinsic fibrinolytic activity (as determined primarily by inhibitors of plasminogen activation) have been documented. Observed periodicities in thrombogenic capacity and cardiovascular events seem to correlate directly, suggesting a cause-effect relationship. Circadian variations in thrombotic tendency may influence the therapeutic response to anticoagulants and thrombolytic agents, particularly rt-PA. This area of cardiovascular disease is of profound clinical importance and warrants further investigation.